These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27061141)

  • 1. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
    Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A
    J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery.
    Ewe A; Noske S; Karimov M; Aigner A
    Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31726756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo.
    Ewe A; Panchal O; Pinnapireddy SR; Bakowsky U; Przybylski S; Temme A; Aigner A
    Nanomedicine; 2017 Jan; 13(1):209-218. PubMed ID: 27553077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.
    Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A
    J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
    J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes.
    Höbel S; Loos A; Appelhans D; Schwarz S; Seidel J; Voit B; Aigner A
    J Control Release; 2011 Jan; 149(2):146-58. PubMed ID: 20946922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery.
    Ewe A; Schaper A; Barnert S; Schubert R; Temme A; Bakowsky U; Aigner A
    Acta Biomater; 2014 Jun; 10(6):2663-73. PubMed ID: 24590163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined disulfide cross-linking and tyrosine-modification of very low molecular weight linear PEI synergistically enhances transfection efficacies and improves biocompatibility.
    Karimov M; Appelhans D; Ewe A; Aigner A
    Eur J Pharm Biopharm; 2021 Apr; 161():56-65. PubMed ID: 33582186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo.
    Karimov M; Schulz M; Kahl T; Noske S; Kubczak M; Gockel I; Thieme R; Büch T; Reinert A; Ionov M; Bryszewska M; Franke H; Krügel U; Ewe A; Aigner A
    Nanomedicine; 2021 Aug; 36():102403. PubMed ID: 33932594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
    Höbel S; Aigner A
    Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tyrosine-modified low molecular weight branched and linear polyethylenimines for siRNA delivery.
    Kubczak M; Michlewska S; Karimov M; Ewe A; Aigner A; Bryszewska M; Ionov M
    Nanotoxicology; 2022; 16(9-10):867-882. PubMed ID: 36697400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
    Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
    Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition.
    Bonnet ME; Gossart JB; Benoit E; Messmer M; Zounib O; Moreau V; Behr JP; Lenne-Samuel N; Kedinger V; Meulle A; Erbacher P; Bolcato-Bellemin AL
    J Control Release; 2013 Sep; 170(2):183-90. PubMed ID: 23727288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells.
    Parmar MB; Arteaga Ballesteros BE; Fu T; K C RB; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    J Biomed Mater Res A; 2016 Dec; 104(12):3031-3044. PubMed ID: 27465922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.